Taurine in Peripartum Cardiomyopathy

Ain Shams University

Status and phase: Completed; Phase 3; Phase 2

Conditions: Peripartum Cardiomyopathy

Treatments: Dietary Supplement: Normal Saline; Drug: Taurine Solution

Study type: Interventional

Funder types: Other

Identifiers

NCT03907267

AS1755

Details and patient eligibility

About

Taurine as an adjunct for early left ventricular recovery in peripartum cardiomyopathy

Enrollment: 40 patients

Sex: Female

Ages: 18 to 40 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Peripartum Cardiomyopathy

Exclusion criteria

• Other identifiable cause for heart failure
• low LVEF ≤ 25%
• sepsis
• autoimmune disease
• severe chronic disease
• malignancy

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Quadruple Blind

---

40 participants in 2 patient groups, including a placebo group

Taurine

Experimental group

Treatment:

Drug: Taurine Solution

Saline

Placebo Comparator group

Treatment:

Dietary Supplement: Normal Saline